Clinical Trial: Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers
Sponsor and Collaborators
AVEO Pharmaceuticals, Inc.
Contact
Contact: Ferry Eskens, MD, PhD
+31 (10) 463-4897
Contact: Elisabeth de Vries, MD
+31 (50) 361 28 21
Principal Investigators
Ferry Eskens, MD, PhD Erasmus Medical Center; Department of Medical Oncology
ClinicalTrials.gov Identifier
NCT00660153
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.